We performed gene profiling and BETi downregulate a BET-specific core gene signature in OCI-AML3 and IMS-M2 cells demonstrating that BETi trigger a common core gene signature reported for NPM1c AML. The gene discussed is RUNX2; the disease is acute myeloid leukemia.